BBLGWNasdaq United States
Market cap
—
Revenue
—
Not reported
Earnings
-$3.11M
Loss-making
Shares outstanding
2,756,057
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Other share classes
Bone Biologics lists more than one class of stock. Company figures above cover all classes combined.
Where these numbers come from
Share counts and financials for Bone Biologics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 24 Sept 2026. Read the methodology.